Efficacy and Safety Study of TLC388 to Advanced Hepatocellular Carcinoma

Clinical trial NCT02267213 · TERMINATED

Trial details

NCT number: NCT02267213
Sponsor: Taiwan Liposome Company
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Hepatocellular Carcinoma

Start date: 2014-04-10
Primary completion: 2015-07-09
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.